Speakers

Harry Erba, B Mark Evers, Roger Fleischman, Amit Goldberg, Roger Herzig, Gerhard Hildebrandt, Joseph Maly, David Moliterno, Gregory Monohan, Reshma Ramlal, Damiano Rondelli, Hayder Saeed, Edward Stadtmauer

Harry Erba, MD, PhD

Professor & Associate Director for Clinical Research
Division of Hematology
University of Alabama at Birmingham College of Medicine
Birmingham, Alabama

Dr. Erba received his M.D. and Ph.D. degrees from Stanford University. He did his internship and residency in internal medicine at the Brigham and Women's Hospital, Harvard Medical School. Following a fellowship in hematology/oncology at the same institution, he joined the Harvard Medical School faculty for 3 years until he moved to the University of Michigan at Ann Arbor where he rose to the rank of Associate Professor.Over the past decade Dr. Erba has become a highly respected leader in the field of hematologic malignancies, especially with respect to the assessment of novel therapies in acute myeloid leukemia, chronic myeloid leukemia and myelodysplastic syndromes. He is an executive officer of SWOG (formerly, Southwest Oncology Group), working closely with the leadership of the SWOG leukemia, lymphoma, myeloma and bone marrow transplant committees. He is an active member in the SWOG leukemia committee and will become chair in the next month.

He has served on the National Comprehensive Cancer Network (NCCN) Practice Guidelines Committees for acute myeloid leukemia, chronic myeloid leukemia, myelodysplastic syndromes and myeloid growth factors. He was given Special Recognition and Appointment to the NCCN Board of Producers in 2007 and 2008. He has been involved in numerous clinical trials in hematologic malignancies, led many national trials as a chair or co-chair, and played major roles in the development of several new drugs. He was named Teacher of the Year in the Division of Hematology/Oncology for four consecutive years at the University of Michigan. In 2004 he was given the Outstanding Clinician Award by the Dean of the University of Michigan Medical School, and this year was appointed as an inaugural member of the League of Clinical Excellence at the University of Michigan.

His work has been published in high-impact journals such as Nature, Cell, Journal of Clinical Oncology, Blood, Cancer Research and British Journal of Haematology. In addition to 47 peer-reviewed publications, he has authored five book chapters and has lectured extensively in the US, Canada, Europe and Japan.

Back to top

B Mark Evers, MD

Director, Markey Cancer Center
Professor and Vice Chair for Research
Department of Surgery
College of Medicine
University of Kentucky
Lexington, Kentucky

Since 2009 Dr. Evers has served as Director of Markey Cancer Center; Professor and Vice-Chair, Department of Surgery; Markey Cancer Foundation Endowed Chair; and Physician-in-Chief, Oncology Service Line with the University of Kentucky. He earned his MD from the University of Tennessee and performed his General Surgery residency at the University of Louisville. After completing a Gastrointestinal Physiology fellowship at the University of Texas Medical Branch, he joined the UTMB faculty. During his 20 years there he filled many roles, including the Robertson-Poth Distinguished Chair in General Surgery, Director of the Sealy Center for Cancer Cell Biology, and Director of the UTMB Comprehensive Cancer Center. Dr. Evers has received more than 30 awards and held several leadership positions in national organizations. His many research projects, which include a SPORE and NIH MERIT awards, have been continuously funded by the NIH for the past 20 years. He holds three patents, has authored more than 300 publications, and serves on several editorial and review boards.

Back to top

Roger Fleischman, MD

Associate Professor
Division of Hematology/BMT
University of Kentucky College of Medicine
Lexington, Kentucky

Roger A. Fleischman received his undergraduate and medical degrees from Harvard College and Harvard Medical School in Cambridge, Mass. After a medical residency at the Brigham and Women’s Hospital in Boston, he completed a fellowship in Hematology and Oncology at the University of Pennsylvania School of Medicine in Philadelphia. During the fellowship, he also engaged in basic research in the biology of blood and bone marrow stem cells at the Institute for Cancer Research at the Fox Chase Cancer Center in Philadelphia.

Dr. Fleischman accepted his first faculty position in Hematology/Oncology at the University of Texas Southwestern Medical School, Dallas in 1983 and served as a practicing clinician at Parkland Memorial Hospital in Dallas as well as a clinical and basic researcher into the molecular causes of bone marrow and stem cell disorders.

In 1993, Dr. Fleischman left Texas for the University of Kentucky and was appointed an Associate Professor of Internal Medicine in the Hematology/Oncology Division. As part of his duties at UK HealthCare, he also serves as Chief of the Hematology/Oncology Section at the Lexington VA Hospital. At UK HealthCare, he see patients primarily with lymphoma, leukemia, and other bone marrow disorders.

Dr. Fleischman has published many research papers and abstracts and my research has been presented at numerous meetings both national and international. He was also recently recognized by the Hematology/Oncology fellows for outstanding teaching. He received 2015 designation as a Distinguished Emeritus Member by the American Society of Hematology for “exemplary service and efforts in the advancement of the field of hematology”. He is married to Dr. Elizabeth Piercy, an Infectious Disease specialist in private practice in Lexington, and they have two daughters.

Back to top

Amit Goldberg, MD

Assistant Professor
Division of Hematology/BMT
University of Kentucky College of Medicine
Lexington, Kentucky

Back to top

Roger Herzig, MD

Professor/Director of Blood and Marrow Transplantation
Division of Hematology/BMT
University of Kentucky
Lexington, Kentucky

My name is Roger Herzig; I received my medical degree from Case Western Reserve University, School of Medicine, Cleveland. I completed fellowships in Hematology at Case Western Reserve University, Cleveland and the National Cancer Institute, Bethesda, Md.

Back to top

Gerhard Hildebrandt, MD

Professor, Medicine
University of Kentucky College of Medicine
Division Chief, Hematology and Blood & Marrow Transplantation
UK HealthCare
Lexington, Kentucky

Dr. Hildebrandt earned a medical degree from the Johannes Gutenberg University of Mainz Medical School, Germany. Upon completing his doctoral research thesis, he was awarded the "doctor medicinae" with magna cum laude. He completed a residency in Internal Medicine and a Hematology and Oncology fellowship at the University of Regensburg, Germany, and became Bone Marrow Transplant and Hematologic Malignancies Attending at the University of Regensburg. In 2009, he was awarded the "Habilitation", the highest academic qualification a scholar can achieve by own pursuit in Germany.

After moving to the United States, he was a faculty member at the Louisiana State University in Shreveport and at the University of Utah. He was the director of the bone marrow transplant program at LSUHSC Shreveport and director of the Utah Blood and Marrow Transplant program at the Huntsman Cancer Institute/University of Utah before moving to Kentucky.

He is a member of ASH, ASCO, ASBMT, AACR, the author of more than forty articles, books, and book chapters and is strongly involved in clinical trials.

Dr. Hildebrandt focuses on patients with cancers of the blood and lymph system, patients before and after blood or marrow stem cell transplantation, and on patients suffering from acute and chronic graft versus host disease.

Back to top

Joseph Maly, MD

Professor
Division of Hematology
Norton Healthcare
Shelbyville, Kentucky

Back to top

David Moliterno, MD

Jack M. Gill Chair and Professor
Department of Internal Medicine
University of Kentucky
Lexington, Kentucky

David J. Moliterno, MD, FACP, FACC is the Jack M. Gill Chair and Professor of the Department of Internal Medicine at the University of Kentucky. He received a bachelor’s degree with honors from the University of Michigan, his medical degree from the Medical College of Virginia, and his Internal Medicine training from Vanderbilt University. He completed a fellowship in Cardiovascular Medicine at The University of Texas-Southwestern Medical Center, and he completed an additional interventional cardiology fellowship at The Cleveland Clinic Foundation, where he remained as an attending cardiologist for 10 years before joining the University of Kentucky.

Dr. Moliterno has been a visiting professor or invited lecturer in more than 30 countries. He is the author or coauthor of over 350 publications and editor of 7 textbooks. He has been the primary author of publications in Annals of Internal Medicine, Circulation, JACC, JAMA, Lancet, BMJ, and the New England Journal of Medicine. He was recently selected to be the Editor-in-Chief for the Journal of the American College of Cardiology—Cardiovascular Interventions. As a clinical researcher, Dr. Moliterno has been a leader in numerous multinational investigational studies. Collectively, these studies have involved over $1 billion in clinical trial research. His primary research interests involve acute coronary syndromes, antithrombotic therapies, and interventional cardiology.

Back to top

Gregory Monohan, MD

Associate Professor
Department of Hematology and Blood & Marrow Transplantation
Fellowship Director, Hematology/Medical Oncology
Markey Cancer Center
University of Kentucky
Lexington, Kentucky

Dr. Monohan received his MD from the University of Kentucky College of Medicine. He served his residency with the Indiana University School of Medicine and a fellowship with the University of Kentucky. Dr. Monohan's clinical interests include benign and malignant hematology, blood and marrow transplantation and multiple myeloma. He is certified with the American Board of Internal Medicine, Hematology and Medical Oncology.

Back to top

Reshma Ramlal, MD

Assistant Professor
Division of Hematology/BMT
University of Kentucky
Lexington, Kentucky

Dr. Reshma Ramlal is hematologist in Lexington, KY and is affiliated with University of Kentucky Albert B. Chandler Hospital. She received her medical degree from the University of the West Indies , Faculty of Medical Science, Port of Spain and received her residency training at the University of Florida Health Science Center in Jacksonville, FL. She received her hematology/oncology fellowship training at St. Louis University Hospital and stem cell transplantation training at the University of Texas, MD Anderson Cancer Center in Houston, TX. She has been in practice for 8 years.

Back to top

Damiano Rondelli, MD

Michael Reese Professor of Hematology
Chief of the Division of Hematology/Oncology
Director, Blood and Marrow Transplant Program
Associate Director for Clinical Research, University of Illinois Cancer Center
Chicago, Illinois

Damiano Rondelli graduated at the Medical School of the University of Bologna, Italy, where he also completed his training in Hematology. He started his research on hematopoietic stem cell transplant immunology as Research Associate at the Fred Hutchinson Cancer Research Center in Seattle, WA. He was then Assistant Professor at the University of Bologna where he established his lab research and clinical work in the Allogeneic Bone Marrow Transplant unit. In 2002 he moved to the University of Illinois at Chicago as Director of the Blood and Marrow Transplant Program and in 2013 he was appointed Chief of the Division of Hematology/Oncology. Since 2011 he has been actively involved in a joint project between UIC and the Binaytara Foundation to advance medical knowledge in Nepal and to start the first Blood and Marrow Transplant of the country in Kathmandu.

He is the Principal Investigator of clinical studies in stem cell transplantation for hematologic malignancies, such as high risk leukemia, lymphoma or myeloma, or myelofibrosis, and for patients with sickle cell anemia. He authored over 100 articles in peer-reviewed journals, multiple book chapters. He is the Editor of an Italian book on the history of medicine (Storia delle Discipline Mediche, Edizioni Hippocrates, Milano, 1999 and 2003).

Back to top

Hayder Saeed, MD

Assistant Professor
Hematology and Medical Oncology
University of Kentucky
Lexington Kentucky

Dr. Hayder Saeed is a medical oncologist in Lexington, Kentucky and is affiliated with University of Kentucky Albert B. Chandler Hospital. He received his medical degree from University of Baghdad College of Medicine and has been in practice between 6-10 years.

Back to top

Edward Stadtmauer, MD

Chief, Hematologic Malignancies
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania

Dr. Edward Stadtmauer completed his medical degree at the University of Pennsylvania School of Medicine, and served his internship and residency in internal medicine at Albert Einstein College of Medicine, Bronx, New York. He completed his fellowship in hematology-oncology at the University of Pennsylvania where he is currently the director of the Bone Marrow and Stem Cell Transplant Program, as well as chief, hematologic malignancies.

Board certified in internal medicine, hematology, and medical oncology, Dr. Stadtmauer is a reviewer for numerous journals and is on the editorial board of the Journal of Clinical Oncology. He is widely published on the subjects of acute and chronic leukemia, autologous bone marrow transplantation, and multiple myeloma. Dr. Stadtmauer’s writings have appeared in peer-reviewed journals such as Annals of Internal Medicine, Blood, Bone Marrow Transplantation, Journal of Clinical Oncology, New England Journal of Medicine, among others.

Back to top